Irlanti - englanti - HPRA (Health Products Regulatory Authority)

le vet beheer b.v. - thiamazole - film-coated tablet - 2.5 mg/tablet - thiamazole - cats - miscellaneous

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

le vet beheer b.v. - thiamazole - film-coated tablet - 5 mg/tablet - thiamazole - cats - miscellaneous

Australia - englanti - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tramadol hydrochloride, quantity: 50 mg - tablet, modified release - excipient ingredients: purified talc; lactose monohydrate; hypromellose; titanium dioxide; propylene glycol; magnesium stearate; macrogol 6000; colloidal anhydrous silica; iron oxide yellow; microcrystalline cellulose - tramal sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. tramal sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. tramal sr is not indicated as an as-needed (prn) analgesia.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 0.1 mg (equivalent: desmopressin, qty 89 microgram) - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; potato starch; povidone - minirin tablets are indicated for the treatment of: cranial diabetes insipidus; primary nocturnal enuresis, in patients from 6 years of age with normal ability to concentrate urine, who are refractory to an enuresis alarm, or in whom an enuresis alarm is contraindicated or inappropriate.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tramadol hydrochloride, quantity: 200 mg - tablet, modified release - excipient ingredients: magnesium stearate; macrogol 6000; titanium dioxide; hypromellose; colloidal anhydrous silica; microcrystalline cellulose; lactose monohydrate; propylene glycol; iron oxide red; iron oxide black; purified talc; quinoline yellow aluminium lake; iron oxide yellow - tramal sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. tramal sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. tramal sr is not indicated as an as-needed (prn) analgesia.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tramadol hydrochloride, quantity: 150 mg - tablet, modified release - excipient ingredients: hypromellose; quinoline yellow aluminium lake; microcrystalline cellulose; purified talc; lactose monohydrate; magnesium stearate; propylene glycol; iron oxide red; colloidal anhydrous silica; macrogol 6000; titanium dioxide - tramal sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. tramal sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. tramal sr is not indicated as an as-needed (prn) analgesia.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tramadol hydrochloride, quantity: 100 mg - tablet, modified release - excipient ingredients: hypromellose; lactose monohydrate; colloidal anhydrous silica; macrogol 6000; magnesium stearate; purified talc; titanium dioxide; microcrystalline cellulose; propylene glycol - tramal sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. tramal sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. tramal sr is not indicated as an as-needed (prn) analgesia.

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - gabapentin - oral tablet - 600mg

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - gabapentin - oral tablet - 800mg

Malta - englanti - Malta Medicines Authority

generics uk limited station close, potters bar, herts, en6 1tl, united kingdom - hydrochlorothiazide, lisinopril - tablet - hydrochlorothiazide 12.5 mg lisinopril 20 mg - agents acting on the renin-angiotensin system